JP2007517006A5 - - Google Patents

Download PDF

Info

Publication number
JP2007517006A5
JP2007517006A5 JP2006546305A JP2006546305A JP2007517006A5 JP 2007517006 A5 JP2007517006 A5 JP 2007517006A5 JP 2006546305 A JP2006546305 A JP 2006546305A JP 2006546305 A JP2006546305 A JP 2006546305A JP 2007517006 A5 JP2007517006 A5 JP 2007517006A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
formula
amino
saturated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006546305A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007517006A (ja
Filing date
Publication date
Priority claimed from GB0330001A external-priority patent/GB0330001D0/en
Priority claimed from GB0416850A external-priority patent/GB0416850D0/en
Application filed filed Critical
Priority claimed from PCT/GB2004/005332 external-priority patent/WO2005060969A1/en
Publication of JP2007517006A publication Critical patent/JP2007517006A/ja
Publication of JP2007517006A5 publication Critical patent/JP2007517006A5/ja
Pending legal-status Critical Current

Links

JP2006546305A 2003-12-24 2004-12-20 Tie2(tek)活性のあるピリミジン Pending JP2007517006A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0330001A GB0330001D0 (en) 2003-12-24 2003-12-24 Compounds
GB0416850A GB0416850D0 (en) 2004-07-29 2004-07-29 Compounds
PCT/GB2004/005332 WO2005060969A1 (en) 2003-12-24 2004-12-20 Pyrimidines with tie2 (tek) activity

Publications (2)

Publication Number Publication Date
JP2007517006A JP2007517006A (ja) 2007-06-28
JP2007517006A5 true JP2007517006A5 (https=) 2008-02-07

Family

ID=34712716

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006546305A Pending JP2007517006A (ja) 2003-12-24 2004-12-20 Tie2(tek)活性のあるピリミジン

Country Status (10)

Country Link
US (1) US20080027076A1 (https=)
EP (1) EP1737462B1 (https=)
JP (1) JP2007517006A (https=)
AR (1) AR046996A1 (https=)
AT (1) ATE402705T1 (https=)
DE (1) DE602004015509D1 (https=)
ES (1) ES2309591T3 (https=)
TW (1) TW200524607A (https=)
UY (1) UY28700A1 (https=)
WO (1) WO2005060969A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT410913B (de) * 2001-08-14 2003-08-25 Schelling Anlagenbau Gmbh Auflagetisch für eine trennsäge mit einem maschinentisch
DE602004018193D1 (de) * 2003-12-24 2009-01-15 Astrazeneca Ab Pyrimidine mit tie2 (tek) aktivität
US7776869B2 (en) * 2004-10-18 2010-08-17 Amgen Inc. Heteroaryl-substituted alkyne compounds and method of use
EP1863805A1 (en) * 2005-02-01 2007-12-12 AstraZeneca AB Pyrimidine compounds having tie2 (tek) inhibitory activity
US20080146599A1 (en) * 2005-02-01 2008-06-19 Astrazeneca Ab Pyrimidine Compounds Having Tie-2 (Tek) Inhibitory Activity
GB0502418D0 (en) * 2005-02-05 2005-03-16 Astrazeneca Ab Compounds
JP2008534565A (ja) * 2005-03-31 2008-08-28 アストラゼネカ アクチボラグ Tie2阻害活性のあるアミノピリミジン誘導体
AU2013201243A1 (en) * 2005-12-23 2013-03-28 Ariad Pharmaceuticals, Inc. Bicyclic heteroaryl compounds
SI1973545T1 (sl) * 2005-12-23 2013-04-30 Ariad Pharmaceuticals, Inc. Spojine bicikličnega heteroarila
AU2015210454B2 (en) * 2005-12-23 2016-10-27 Takeda Pharmaceuticals U.S.A., Inc. Bicyclic heteroaryl compounds
EA034598B1 (ru) * 2005-12-23 2020-02-25 Ариад Фармасьютикалз, Инк. Применение бициклических гетероарильных соединений для лечения рака
US8278307B2 (en) * 2006-05-08 2012-10-02 Ariad Pharmaceuticals, Inc. Monocyclic Heteroaryl compounds
CN103435595A (zh) 2006-05-08 2013-12-11 阿里亚德医药股份有限公司 炔类杂芳基化合物
EP2022785A1 (en) * 2007-06-20 2009-02-11 Bayer Schering Pharma Aktiengesellschaft Alkynylpyrimidines as Tie2 kinase inhibitors
EP2070929A1 (en) * 2007-12-11 2009-06-17 Bayer Schering Pharma Aktiengesellschaft Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
EP2307456B1 (en) 2008-06-27 2014-10-15 Amgen Inc. Ang-2 inhibition to treat multiple sclerosis
WO2010012740A1 (en) 2008-07-29 2010-02-04 Boehringer Ingelheim International Gmbh 5-alkynyl-pyrimidines
CA2743449C (en) 2008-11-12 2016-10-18 Ariad Pharmaceuticals, Inc. Pyrazinopyrazines and derivatives as kinase inhibitors
US8618111B2 (en) * 2010-01-26 2013-12-31 Boehringer Ingelheim International Gmbh 5-alkynyl-pyrimidines
US8633183B2 (en) 2010-01-26 2014-01-21 Boehringer Ingelheim International Gmbh 5-alkynyl-pyrimidines
CA3022250A1 (en) 2012-12-12 2014-06-12 Ariad Pharmaceuticals, Inc. Crystalline forms of 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride
US10065934B2 (en) 2014-07-17 2018-09-04 Sunshine Lake Pharma Co., Ltd. Substituted urea derivatives and pharmaceutical uses thereof
JP6570776B2 (ja) * 2016-06-20 2019-09-04 テグ−キョンプク メディカル イノベーション ファウンデーション 新規のイミダゾピリジン誘導体、その製造方法及びこれを有効成分として含有する癌の予防又は治療用医薬組成物
CN109251181B (zh) * 2017-07-13 2021-08-31 广东东阳光药业有限公司 取代脲衍生物的盐及其在药物中的应用
WO2020013531A1 (ko) * 2018-07-10 2020-01-16 보로노이바이오 주식회사 N-(3-(이미다조[1,2-b]피리다진-3-일에티닐)-4-메틸페닐)-5-페닐-4,5-다이하이드로-1H-피라졸-1-카복사마이드 유도체 및 이를 유효성분으로 포함하는 키나아제 관련 질환 치료용 약학적 조성물
CN110272426B (zh) 2018-07-17 2022-05-31 深圳市塔吉瑞生物医药有限公司 用于抑制蛋白激酶活性的炔基(杂)芳环类化合物
WO2021172931A1 (ko) * 2020-02-28 2021-09-02 재단법인 대구경북첨단의료산업진흥재단 3-((8-((1h-피라졸-4-일)아미노)이미다조[1,2-a]피리딘-3-일)에티닐)-n-페닐벤즈아미드 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 암의 예방 또는 치료용 약학적 조성물

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001062233A2 (en) * 2000-02-25 2001-08-30 F. Hoffmann La Roche Ag Adenosine receptor modulators
JP5154728B2 (ja) * 2000-07-24 2013-02-27 クレニツキー・ファーマシューティカルズ,インコーポレイテッド 神経栄養活性を有する置換5−アルキニルピリミジン
US20030199525A1 (en) * 2002-03-21 2003-10-23 Hirst Gavin C. Kinase inhibitors
US20030225273A1 (en) * 2002-03-21 2003-12-04 Michaelides Michael R. Thiopyrimidine and isothiazolopyrimidine kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2007517006A5 (https=)
JP2007517007A5 (https=)
JP5925394B2 (ja) 抗レトロウイルス剤としての(ヘテロ)アリールアセトアミド誘導体
JP6524081B2 (ja) ジヒドロピリミジン化合物及び医薬におけるその適用
AU2014233414B2 (en) N-acyl-N'-(pyridin-2-yl) ureas and analogs exhibiting anti-cancer and anti-proliferative activities
CN103121996B (zh) 用作mek抑制剂的杂芳基取代的芳基氨基吡啶衍生物
JP5941598B2 (ja) 5員ヘテロアリールおよびそれらの抗ウイルス剤としての使用
KR101551238B1 (ko) 신규한 hiv 역전사효소 억제제
US10202390B2 (en) Heteroaryl substituted aminopyridine compounds
AU2012210489B2 (en) IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation
JP2009534406A5 (https=)
EP2668183A1 (en) Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
CN102361868A (zh) 作为1-磷酸-鞘氨醇激动剂的吡唑-1,2,4-噁二唑衍生物
JP2018526405A5 (https=)
CN103237795B (zh) 经取代的噁二唑化合物及其作为s1p1激动剂的用途
RU2007108863A (ru) Производные пиразола для лечения состояний, опосредованных активацией рецептора аденозина а2в или а3
JP2003529593A5 (https=)
JP2015502371A5 (https=)
KR101536488B1 (ko) 이미다졸 유도체, 그의 제조 방법 및 용도
CN110612286A (zh) 氰基取代的稠合双环衍生物及其制备方法和用途
JP2022505827A (ja) 置換インドール二量体の化合物
JP7620611B2 (ja) IRAK4阻害剤として有用なピラゾロ[3,4-d]ピロロ[1,2-b]ピリダジニル化合物
WO2014069554A1 (ja) キヌクリジンアミド誘導体及びその医薬用途
US20070049608A1 (en) Pyrrolopyridine, pyrrolopyrimidine and pyrazolopyridine compounds, compositions comprising them, and methods of their use
JP7573596B2 (ja) Irak4阻害剤として有用なチエノピリジニルおよびチアゾロピリジニル化合物